Company profile
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests
- CEO
- Mr. Indranil Dey
- Headquarters
- Acton, MA, United States
- Employees
- 6
- IPO date
- Nov 10, 2021
- Sector
- Healthcare
- Industry
- Medical Devices